HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jack Puymirat Selected Research

Myotonin-Protein Kinase

12/2021Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy.
1/2012Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.
4/2005Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells.
5/2003Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jack Puymirat Research Topics

Disease

22Myotonic Dystrophy (Dystrophia Myotonica)
07/2022 - 05/2003
2Rare Diseases (Rare Disease)
01/2020 - 09/2015
2Neuromuscular Diseases (Neuromuscular Disease)
01/2018 - 01/2017
2Muscular Dystrophies (Muscular Dystrophy)
06/2017 - 01/2008
1Neurodevelopmental Disorders
12/2021
1Cognitive Dysfunction
12/2021
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
01/2020
1Inborn Genetic Diseases (Disease, Hereditary)
11/2019
1Muscular Diseases (Myopathy)
11/2019
1Body Weight (Weight, Body)
06/2017
1Muscle Weakness
06/2017
1Myotonia
06/2012
1Sleepiness
05/2012
1Nausea
05/2012
1Diarrhea
05/2012
1Disorders of Excessive Somnolence (Hypersomnia)
05/2012
1Disease Progression
03/2012
1Insulin Resistance
10/2009
1Myotonia Congenita (Thomsen Disease)
02/2008
1Cardiac Conduction System Disease
01/2008

Drug/Important Bio-Agent (IBA)

6RNA (Ribonucleic Acid)IBA
01/2022 - 01/2008
5Biomarkers (Surrogate Marker)IBA
07/2022 - 04/2010
5Antisense OligonucleotidesIBA
01/2022 - 11/2015
53' Untranslated Regions (3' UTR)IBA
01/2022 - 05/2003
4Protein Kinases (Protein Kinase)IBA
01/2022 - 01/2005
4Myotonin-Protein KinaseIBA
12/2021 - 05/2003
2Messenger RNA (mRNA)IBA
01/2020 - 10/2009
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 09/2015
1LigandsIBA
01/2022
1CytosineIBA
01/2022
1GuanineIBA
01/2022
1ThymineIBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2021
1Keratin-14 (Keratin 14)IBA
01/2020
1Peptides (Polypeptides)IBA
11/2019
1Pharmaceutical PreparationsIBA
11/2019
1OligonucleotidesIBA
11/2019
1milk-derived factorIBA
12/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2018
1Carrier Proteins (Binding Protein)IBA
01/2018
1ISIS 486178IBA
06/2017
1Nuclear RNAIBA
01/2017
1Sodium Channels (Sodium Channel)IBA
06/2012
1Methylphenidate (Ritalin)FDA LinkGeneric
05/2012
1Dinoprostone (PGE2)FDA Link
01/2012
1Insulin ReceptorIBA
10/2009
1Chloride Channels (Chloride Channel)IBA
02/2008
1Transcription Factors (Transcription Factor)IBA
01/2008
1Connexin 43 (Connexin43)IBA
01/2008
1Gap Junction alpha-5 ProteinIBA
01/2008
1Catalytic RNA (Ribozymes)IBA
05/2003
1hammerhead ribozymeIBA
05/2003

Therapy/Procedure

2Therapeutics
12/2021 - 01/2020